AKTS:NASDAQ, Akoustis Technologies, Inc.
AKTS stock overview
Akoustis Technologies, Inc. (AKTS:NASDAQ) closed at $16.16 on November 16, 2026,
down 2.77% on the day.
The stock trades 52.7% below its 52-week high of $34.19
and 15.8% above its 52-week low of $13.96.
Akoustis Technologies, Inc. is part of the Public Utilities sector (Telecommunications Equipment).
Key figures
- Price
- $16.16
- Day change
- -2.77%
- Volume
- 597,517
- Average volume
- 389,370
- Market cap
- 901M+
- 52-week range
- $13.96 – $34.19
- 50-day average
- $18.54
- 200-day average
- $20.78
Price action over the past year
In 251 trading sessions since November 14, 2025, AKTS closed higher on 106 days (42%).
Its best day was June 12, 2026 (+12.69%) and its worst was July 6, 2026 (-16.37%).
The stock moved 10% or more in a single session 4 times.
It opened at least 5% above the previous day's high 38 times.
Recent signals
AKTS news
-
Nov 12, 2026:
Aktis: Q3 Earnings Snapshot
-
Nov 12, 2026:
Aktis Oncology Reports Third-Quarter Financial Results and Highlights Clinical Trial Progress
-
Nov 11, 2026:
Does Aktis (AKTS) Have the Potential to Rally 105.62% as Wall Street Analysts Expect?
-
Oct 1, 2026:
Aktis Oncology Initiates Second Phase 1b Clinical Trial for AKY-2519, a Miniprotein Radioconjugate Targeting B7-H3
-
Sep 9, 2026:
Aktis Oncology to Present at Upcoming September Investor Conferences
-
Aug 19, 2026:
Aktis Oncology Seen Advancing Targeted Radiation-Based Cancer Drugs, Wedbush Says
-
Aug 19, 2026:
Why Novartis, Lilly, and Bristol Myers Are Eyeing This Clinical-Stage Cancer Play
About Akoustis Technologies, Inc.
Akoustis Technologies Inc operates in the telecommunications and fiber optics sector. The company designs and manufactures innovative radio frequency (RF) filters enabling the RF front-end (RFFE) of Mobile Wireless devices.
Similar stocks
Find more stocks like AKTS with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.